Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-07-19
2011-07-19
Habte, Kahsay T (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S048000, C544S051000, C544S052000, C514S228500
Reexamination Certificate
active
07981886
ABSTRACT:
The invention relates to antibiotic derivatives of formula Iwherein:A represents —O—, S, —C(═O)—, —C(═NOR6)—;Z—B represents NCH2CH2, NCOCH2, NCH2CO, NCH2CH(OH), CHN(R8)CH2or CHN(R8)CO;D represents binuclear heteroaryl;Y1represents —CR1— or —N—, Y2represents —CR2— or —N—, Y3represents —CR3— or —N— andY4represents —CR4— or —N—;U represents —NH—, —O— or —S— and V represents —N— or —CH—;W represents —CH2—, —O— or —NR7—;R1represents H, methyl, ethyl or halogen;R2, R3and R4each represent independently H, C1-C4alkyl, halogen, or C1-C4alkoxy;R5represents H, C1-C4alkyl or fluorine;R6represents H, C1-C4alkyl or aryl-C1-C4alkyl;R7represents H, C1-C4alkyl, aryl-C1-C4alkyl or —CH2—COOH;R8represents H, C1-C4alkyl or —CH2—COOH;with the provisos thatif Z—B represents NCH2CH2, NCOCH2, NCH2CO or NCH2CH(OH), then W represents —CH2—;if A represents O or S, then W represents —CH2—; andonly one or two of Y1, Y2, Y3and Y4can represent N at the same time.
REFERENCES:
patent: A1-0863139 (1998-09-01), None
patent: WO92/06086 (1991-09-01), None
Vippagunta et al, “Crystalline Solids” Advanced Drug Delivery Reviews, vol. 48, pp. 3-26 (2001).
Gavezzotti, “Are Crystal Structures Predictable?” Accounts of Chemical Research, vol. 27, pp. 309-314 (1994).
Wolff Manfred E. “Burger's Medicinal Chemistry, 5ed, Part 1” John Wiley & Sons, 1995, pp. 975-977.
Banker, G.S. et al, “Modern Pharmaceutices, 3ed.” Marcel Dekker, New York, 1996, pp. 451 and 596.
PCT/IB2006/051661—PCT Notification Concerning Submission or Transmittal of Priority Document.
PCT/IB2006/051661—PCT Request.
PCT/IB2006/051661—PCT Written Opinion.
Bur Daniel
Hubschwerlen Christian
Surivet Jean-Philippe
Zumbrunn-Acklin Cornelia
Actelion Pharmaceutical Ltd.
Habte Kahsay T
Hunton & Williams LLP
LandOfFree
Antibiotics derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibiotics derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibiotics derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2651151